ArticleFrontiers in microbiology2026
Clinical application of targeted next-generation sequencing in detecting organ/space surgical site infection in patients following biliary-pancreatic surgery.
Article in Frontiers in microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Organ/space surgical site infection (SSI) is a common and severe complication following biliary-pancreatic surgery. Rapid and accurate diagnosis is crucial for managing organ/space SSI. The clinical application of targeted next-generation sequencing (tNGS) in biliary-pancreatic surgery remains limited. Methods: This retrospective study enrolled 73 consecutive patients who underwent biliary-pancreatic surgery between January 2025 and June 2025, among whom 27 patients were clinically diagnosed with organ/space SSI. Abdominal drainage specimens were collected and analyzed using tNGS and conventional microbiological tests (CMTs). The diagnostic performance, pathogen spectrum, and turnaround time of the two methods were evaluated. Results: The overall pathogen detection rate was higher for tNGS than for CMTs (52.1% vs. 39.7%). tNGS showed higher sensitivity (92.6% vs. 66.7%) and negative predictive value (94.3% vs. 79.5%) than CMTs in organ/space SSI, with a shorter turnaround time (28.1 h vs. 109.1 h). tNGS revealed a broader pathogenic spectrum than CMTs (23 vs. 12 species). Moreover, advanced age (OR = 1.052, 95%CI = 1.005-1.100 Conclusion: tNGS may provide rapid adjunctive microbiological information for early etiological assessment of organ/space SSI after biliary-pancreatic surgery, but it should complement rather than replace CMTs and clinical assessment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.